April 22, 2025CorporateTerumo unveils “Terumo Group Statement on Nature,” a guideline for its actions on conservation and restoration of natural environments
April 16, 2025CorporateTerumo Blood and Cell Technologies Names Patrick Daly as Chief Business OfficerDaly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth
April 16, 2025CorporateTerumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort –
Shareholders Meeting /investors/stocks/shareholders_meeting Stock Information /investors/stocks/situation Shareholder Return /investors/stocks/return Credit Ratings and Corporate Bond /investors/stocks/rating Analyst Coverage /investors/stocks/analyst Stock Quote /investors/stocks/chart Articles of Incorporation /investors/stocks/regulation
